Castle Biosciences
CSTL
CSTL
153 hedge funds and large institutions have $526M invested in Castle Biosciences in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 55 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
22% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 45
13% more funds holding
Funds holding: 135 → 153 (+18)
4.18% more ownership
Funds ownership: 86.35% → 90.53% (+4.2%)
Holders
153
Holding in Top 10
3
Calls
$148K
Puts
$80K
Top Buyers
| 1 | +$19.8M | |
| 2 | +$10.3M | |
| 3 | +$4.62M | |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$3.67M |
| 5 |
BlackRock
New York
|
+$3.17M |
Top Sellers
| 1 | -$6.93M | |
| 2 | -$5.56M | |
| 3 | -$4.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.09M |
| 5 |
Walleye Capital
New York
|
-$2.88M |